BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12862258)

  • 1. A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient.
    Bhat RM; Radhakrishnan K
    Lepr Rev; 2003 Jun; 74(2):167-70. PubMed ID: 12862258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone agranulocytosis in a leprosy patient.
    Hiran S; Pande TK; Pani S; Vishwanathan KA
    Lepr Rev; 1994 Sep; 65(3):279-81. PubMed ID: 8942159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total agranulocytosis caused by dapsone therapy for tuberculoid leprosy--an unappreciated serious side effect of anti-leprosy treatment with clinical implications.
    Satarasinghe RL; Jayawardana MA; De Silva GV; Murugathas S; Riyaaz AA; Wickrmasingha UD; Wijesinghe R
    Drug Metabol Drug Interact; 2009; 24(2-4):325-9. PubMed ID: 20408505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone-induced motor polyneuropathy in a patient with leprosy.
    Pavithran K; Satish TC
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):262-3. PubMed ID: 9251603
    [No Abstract]   [Full Text] [Related]  

  • 6. An unusual presentation of facial palsy in leprosy; a case report.
    Thompson K
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):567-9. PubMed ID: 8642221
    [No Abstract]   [Full Text] [Related]  

  • 7. Early onset dapsone syndrome.
    Singal A; Sharma SC; Baruah MC; Gautam RK
    Indian J Lepr; 1993; 65(4):443-5. PubMed ID: 8182292
    [No Abstract]   [Full Text] [Related]  

  • 8. Agranulocytosis--a case report.
    Rahman J; Chowdhury SA; Wajed J
    Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):65-8. PubMed ID: 11508074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
    Ranawaka RR; Mendis S; Weerakoon HS
    Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone induced methaemoglobinaemia.
    Diwan SK; Sharma AK; Jain AP; Gupta OP; Jajoo UN
    Indian J Lepr; 1991; 63(1):103-5. PubMed ID: 1919080
    [No Abstract]   [Full Text] [Related]  

  • 11. Investigations into the haemolytic effects of dapsone therapy in leprosy patients.
    Balakrishnan S; Karthikeyan S; Ramu G
    Indian J Lepr; 1989 Jan; 61(1):10-6. PubMed ID: 2703739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leprosy: not always an easy diagnosis and often a management challenge.
    Manifold R; Marshman G
    Australas J Dermatol; 2009 Feb; 50(1):36-40. PubMed ID: 19178490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dapsone-induced agranulocytosis in a patient of leprosy.
    Mishra M; Chhetia R
    Indian J Dermatol Venereol Leprol; 2006; 72(6):456-7. PubMed ID: 17179627
    [No Abstract]   [Full Text] [Related]  

  • 14. Agranulocytosis during multidrug therapy (MDT) of leprosy.
    Reeve P
    Lepr Rev; 1992 Mar; 63(1):82-3. PubMed ID: 1569822
    [No Abstract]   [Full Text] [Related]  

  • 15. Dapsone syndrome.
    Hiran S; Pande TK; Rizvi SA; Vishwanathan KA
    J Assoc Physicians India; 1994 Jun; 42(6):497. PubMed ID: 7852239
    [No Abstract]   [Full Text] [Related]  

  • 16. Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
    Asz-Sigall D; López-García L; Neme-Yunes Y; Yuen-Palos R; Vega-Memije ME; Arenas R
    Int J Dermatol; 2008 Oct; 47(10):1084-6. PubMed ID: 18986365
    [No Abstract]   [Full Text] [Related]  

  • 17. Agranulocytosis due to dapsone.
    Firkin FC; Mariani AF
    Med J Aust; 1977 Aug; 2(8):247-51. PubMed ID: 909500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone-induced agranulocytosis-possible involvement of low-activity N-acetyltransferase 2.
    Potočnjak I; Likić R; Šimić I; Juričić Nahal D; Čegec I; Ganoci L; Božina N
    Fundam Clin Pharmacol; 2017 Oct; 31(5):580-586. PubMed ID: 28322460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17 Response of Borderline-Lepromatous Leprosy Inhibits Rash Manifestation of Dapsone Hypersensitivity Syndrome: Case Report.
    de Nardo Vanzela T; Bernardes Filho F; Wambier CG; Faria FM; Foss NT; Frade MAC
    Am J Dermatopathol; 2018 Mar; 40(3):205-208. PubMed ID: 28937434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dapsone-induced photodermatitis in a patient with leprosy].
    Fumey SM
    Z Hautkr; 1988 Jan; 63(1):53-4. PubMed ID: 3354248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.